Theragene Pharmaceuticals' Unattributed - II Round

Theragene Pharmaceuticals raised a round of funding on August 11, 2015.

Theragene Pharmaceuticals combines innovative science and efficiency to develop life-saving therapies for many debilitating diseases. As a biopharmaceutical company operating in both the US and Asia, …

Articles about Theragene Pharmaceuticals' Unattributed - II Round: